KVUE – Kenvue Inc
KVUE — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
2.73
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
19.27
Target Price
19.67
Analyst Recom
2.71
Performance Q
0.57
Upside
-40.8%
Beta
0.39
Ticker: KVUE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-15 | KVUE | 18.66 | 0.50 | 0.26 | 134118 |
| 2026-10-16 | KVUE | 18.9 | 0.50 | 0.19 | 134633 |
| 2026-10-19 | KVUE | 18.86 | 0.50 | 1.48 | 131498 |
| 2026-10-20 | KVUE | 19.29 | 0.52 | 0.17 | 133482 |
| 2026-10-21 | KVUE | 19.05 | 0.52 | 0.70 | 136756 |
| 2026-10-22 | KVUE | 19.89 | 0.52 | 0.33 | 137762 |
| 2026-10-23 | KVUE | 19.57 | 0.53 | 0.74 | 138016 |
| 2026-10-26 | KVUE | 19.5 | 0.54 | 0.87 | 135483 |
| 2026-10-27 | KVUE | 19.43 | 0.54 | 0.98 | 136412 |
| 2026-10-28 | KVUE | 19.33 | 0.54 | 2.17 | 138192 |
| 2026-10-29 | KVUE | 19.57 | 0.55 | 0.86 | 139263 |
| 2026-10-30 | KVUE | 19.48 | 0.54 | 0.79 | 141486 |
| 2026-11-02 | KVUE | 19.31 | 0.54 | 0.77 | 141486 |
| 2026-11-03 | KVUE | 19.31 | 0.54 | 0.77 | 141486 |
| 2026-11-04 | KVUE | 19.31 | 0.54 | 0.77 | 141486 |
| 2026-11-05 | KVUE | 19.31 | 0.54 | 0.77 | 141486 |
| 2026-11-06 | KVUE | 19.31 | 0.54 | 0.77 | 141486 |
| 2026-11-09 | KVUE | 19.31 | N/A | N/A | 0 |
| 2026-11-10 | KVUE | 19.31 | N/A | N/A | 0 |
| 2026-11-11 | KVUE | 19.31 | N/A | N/A | 0 |
| 2026-11-12 | KVUE | 19.31 | N/A | N/A | 0 |
| 2026-11-13 | KVUE | 19.31 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-15 | KVUE | 18.67 | 5.2 | 721.3 | 1.18 |
| 2026-10-16 | KVUE | 18.90 | 5.0 | 618.4 | 1.18 |
| 2026-10-19 | KVUE | 18.86 | 5.0 | 579.1 | 1.18 |
| 2026-10-20 | KVUE | 18.86 | 5.0 | 579.1 | 1.18 |
| 2026-10-21 | KVUE | 19.30 | 5.0 | 640.0 | 1.18 |
| 2026-10-22 | KVUE | 19.89 | 5.0 | 705.2 | 1.18 |
| 2026-10-23 | KVUE | 19.56 | 5.0 | 540.9 | 1.18 |
| 2026-10-26 | KVUE | 19.50 | 5.0 | 575.1 | 1.18 |
| 2026-10-27 | KVUE | 19.43 | 5.0 | 575.8 | 1.18 |
| 2026-10-28 | KVUE | 19.33 | 5.0 | 562.0 | 1.18 |
| 2026-10-29 | KVUE | 19.57 | 5.0 | 618.9 | 1.18 |
| 2026-10-30 | KVUE | 19.27 | 5.0 | 545.5 | 1.18 |
| 2026-11-02 | KVUE | 19.27 | 5.0 | 499.9 | 1.18 |
| 2026-11-03 | KVUE | 19.27 | - | - | - |
| 2026-11-04 | KVUE | 19.27 | - | - | - |
| 2026-11-05 | KVUE | 19.27 | - | - | - |
| 2026-11-06 | KVUE | 19.27 | - | - | - |
| 2026-11-09 | KVUE | 19.27 | - | - | - |
| 2026-11-10 | KVUE | 19.27 | - | - | - |
| 2026-11-11 | KVUE | 19.27 | - | - | - |
| 2026-11-12 | KVUE | 19.27 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-15 | KVUE | -0.87 | 1.09 | 3.01 |
| 2026-10-16 | KVUE | -0.87 | 1.09 | 3.01 |
| 2026-10-19 | KVUE | -0.87 | 1.01 | 3.01 |
| 2026-10-20 | KVUE | -0.87 | 1.01 | 3.01 |
| 2026-10-21 | KVUE | -0.87 | 1.01 | 3.01 |
| 2026-10-22 | KVUE | -0.87 | 1.01 | 3.01 |
| 2026-10-23 | KVUE | -0.87 | 1.01 | 3.01 |
| 2026-10-26 | KVUE | -0.87 | 0.91 | 3.01 |
| 2026-10-27 | KVUE | -0.87 | 0.91 | 2.91 |
| 2026-10-28 | KVUE | -0.87 | 0.91 | 2.91 |
| 2026-10-29 | KVUE | -0.87 | 0.91 | 2.91 |
| 2026-10-30 | KVUE | -0.87 | 0.91 | 2.91 |
| 2026-11-02 | KVUE | -0.87 | 0.95 | 2.91 |
| 2026-11-03 | KVUE | -0.87 | 0.95 | 2.91 |
| 2026-11-05 | KVUE | -0.87 | 0.95 | 2.91 |
| 2026-11-06 | KVUE | -0.87 | 0.95 | 2.91 |
| 2026-11-09 | KVUE | -0.87 | 0.95 | 2.91 |
| 2026-11-10 | KVUE | -0.87 | 0.95 | 2.91 |
| 2026-11-11 | KVUE | -0.87 | 0.95 | 2.73 |
| 2026-11-12 | KVUE | -0.87 | 0.95 | 2.73 |
| 2026-11-13 | KVUE | -0.08 | 0.95 | 2.73 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
-0.08
Institutional Transactions
0.95
Beta
0.39
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
Growth Score
21
Sentiment Score
81
Actual DrawDown %
30.7
Max Drawdown 5-Year %
Target Price
19.67
P/E
21.97
Forward P/E
15.53
PEG
2.15
P/S
2.39
P/B
3.65
P/Free Cash Flow
15.86
EPS
0.88
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
10.88
Relative Volume
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
KVUE
Consumer Defensive
$19.31
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
60
Range 1M
75.7%
Sup Dist
1.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
8.4%
EPS NY
6.3%
52W%
86.5%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-20.9% upside
Upside
-20.9%
KVUE — P/E HistoricalHousehold & Personal Products
Kenvue Inc.Sector: Consumer Defensive
Industry: Household & Personal Products
Employees: 21780
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
KVUE
Latest News
—
Caricamento notizie per KVUE…
stock quote shares KVUE – Kenvue Inc Stock Price stock today
news today KVUE – Kenvue Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch KVUE – Kenvue Inc yahoo finance google finance
stock history KVUE – Kenvue Inc invest stock market
stock prices KVUE premarket after hours
ticker KVUE fair value insiders trading